Smith A[au] - Search Results

Year	Number of Results
1819	1
1821	2
1822	1
1823	1
1840	3
1841	2
1842	2
1855	1
1856	2
1862	1
1863	2
1865	2
1866	1
1867	2
1868	3
1869	3
1870	1
1871	1
1873	1
1877	1
1878	1
1879	2
1880	1
1881	1
1882	1
1883	2
1885	1
1887	1
1888	2
1889	1
1892	1
1895	1
1898	3
1900	1
1905	2
1908	2
1909	4
1910	1
1912	1
1913	1
1915	1
1916	2
1917	1
1918	6
1919	3
1920	1
1921	2
1923	1
1924	2
1926	1
1927	5
1928	2
1929	4
1930	2
1931	4
1932	3
1933	4
1934	6
1935	2
1936	6
1937	7
1938	2
1940	2
1941	8
1943	2
1945	5
1946	24
1947	23
1948	24
1949	38
1950	29
1951	29
1952	33
1953	38
1954	34
1955	39
1956	35
1957	37
1958	39
1959	47
1960	36
1961	20
1962	64
1963	52
1964	50
1965	53
1966	63
1967	58
1968	68
1969	81
1970	72
1971	92
1972	101
1973	118
1974	121
1975	138
1976	114
1977	145
1978	120
1979	168
1980	130
1981	139
1982	158
1983	183
1984	182
1985	208
1986	230
1987	223
1988	218
1989	206
1990	225
1991	250
1992	265
1993	249
1994	264
1995	277
1996	311
1997	291
1998	305
1999	302
2000	358
2001	402
2002	406
2003	437
2004	467
2005	565
2006	507
2007	571
2008	595
2009	659
2010	660
2011	780
2012	817
2013	831
2014	886
2015	920
2016	950
2017	1011
2018	1005
2019	1061
2020	1178
2021	1286
2022	697

1

Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia.

Peffault de Latour R, Kulasekararaj A, Iacobelli S, Terwel SR, Cook R, Griffin M, Halkes CJM, Recher C, Barraco F, Forcade E, Vallejo JC, Drexler B, Mear JB, Smith AE, Angelucci E, Raymakers RAP, de Groot MR, Daguindau E, Nur E, Barcellini W, Russell NH, Terriou L, Iori AP, La Rocca U, Sureda A, Sánchez-Ortega I, Xicoy B, Jarque I, Cavenagh J, Sicre de Fontbrune F, Marotta S, Munir T, Tjon JML, Tavitian S, Praire A, Clement L, Rabian F, Marano L, Hill A, Palmisani E, Muus P, Cacace F, Frieri C, van Lint MT, Passweg JR, Marsh JCW, Socié G, Mufti GJ, Dufour C, Risitano AM; Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation. Peffault de Latour R, et al. Among authors: smith ae. N Engl J Med. 2022 Jan 6;386(1):11-23. doi: 10.1056/NEJMoa2109965. N Engl J Med. 2022. PMID: 34986284 Clinical Trial.

2

Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer.

Makker V, Colombo N, Casado Herráez A, Santin AD, Colomba E, Miller DS, Fujiwara K, Pignata S, Baron-Hay S, Ray-Coquard I, Shapira-Frommer R, Ushijima K, Sakata J, Yonemori K, Kim YM, Guerra EM, Sanli UA, McCormack MM, Smith AD, Keefe S, Bird S, Dutta L, Orlowski RJ, Lorusso D; Study 309–KEYNOTE-775 Investigators. Makker V, et al. Among authors: smith ad. N Engl J Med. 2022 Feb 3;386(5):437-448. doi: 10.1056/NEJMoa2108330. Epub 2022 Jan 19. N Engl J Med. 2022. PMID: 35045221 Clinical Trial.

3

NEAT1 is essential for metabolic changes that promote breast cancer growth and metastasis.

Park MK, Zhang L, Min KW, Cho JH, Yeh CC, Moon H, Hormaechea-Agulla D, Mun H, Ko S, Lee JW, Jathar S, Smith AS, Yao Y, Giang NT, Vu HH, Yan VC, Bridges MC, Kourtidis A, Muller F, Chang JH, Song SJ, Nakagawa S, Hirose T, Yoon JH, Song MS. Park MK, et al. Among authors: smith as. Cell Metab. 2021 Dec 7;33(12):2380-2397.e9. doi: 10.1016/j.cmet.2021.11.011. Cell Metab. 2021. PMID: 34879239

4

Smith-Magenis Syndrome.

Smith ACM, Boyd KE, Brennan C, Charles J, Elsea SH, Finucane BM, Foster R, Gropman A, Girirajan S, Haas-Givler B. Smith ACM, et al. 2001 Oct 22 [updated 2022 Mar 10]. In: Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews^® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2022. 2001 Oct 22 [updated 2022 Mar 10]. In: Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews^® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2022. PMID: 20301487 Free Books & Documents. Review.

5

Use of whole genome sequencing to determine genetic basis of suspected mitochondrial disorders: cohort study.

Schon KR, Horvath R, Wei W, Calabrese C, Tucci A, Ibañez K, Ratnaike T, Pitceathly RDS, Bugiardini E, Quinlivan R, Hanna MG, Clement E, Ashton E, Sayer JA, Brennan P, Josifova D, Izatt L, Fratter C, Nesbitt V, Barrett T, McMullen DJ, Smith A, Deshpande C, Smithson SF, Festenstein R, Canham N, Caulfield M, Houlden H, Rahman S, Chinnery PF; Genomics England Research Consortium. Schon KR, et al. Among authors: smith a. BMJ. 2021 Nov 3;375:e066288. doi: 10.1136/bmj-2021-066288. BMJ. 2021. PMID: 34732400 Free PMC article. Clinical Trial.

6

HER2 + breast cancers evade anti-HER2 therapy via a switch in driver pathway.

Smith AE, Ferraro E, Safonov A, Morales CB, Lahuerta EJA, Li Q, Kulick A, Ross D, Solit DB, de Stanchina E, Reis-Filho J, Rosen N, Arribas J, Razavi P, Chandarlapaty S. Smith AE, et al. Nat Commun. 2021 Nov 18;12(1):6667. doi: 10.1038/s41467-021-27093-y. Nat Commun. 2021. PMID: 34795269 Free PMC article.

7

Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG Study.

Nowak RJ, Coffey CS, Goldstein JM, Dimachkie MM, Benatar M, Kissel JT, Wolfe GI, Burns TM, Freimer ML, Nations S, Granit V, Smith AG, Richman DP, Ciafaloni E, Al-Lozi MT, Sams LA, Quan D, Ubogu E, Pearson B, Sharma A, Yankey JW, Uribe L, Shy M, Amato AA, Conwit R, O'Connor KC, Hafler DA, Cudkowicz ME, Barohn RJ; NeuroNEXT NN103 BeatMG Study Team. Nowak RJ, et al. Among authors: smith ag. Neurology. 2021 Dec 2;98(4):e376-89. doi: 10.1212/WNL.0000000000013121. Online ahead of print. Neurology. 2021. PMID: 34857535

8

Model-Free or Not?

Zumpfe K, Smith AA. Zumpfe K, et al. Among authors: smith aa. Front Mol Biosci. 2021 Oct 25;8:727553. doi: 10.3389/fmolb.2021.727553. eCollection 2021. Front Mol Biosci. 2021. PMID: 34760924 Free PMC article. Review.

9

Direct on-swab metabolic profiling of vaginal microbiome host interactions during pregnancy and preterm birth.

Pruski P, Correia GDS, Lewis HV, Capuccini K, Inglese P, Chan D, Brown RG, Kindinger L, Lee YS, Smith A, Marchesi J, McDonald JAK, Cameron S, Alexander-Hardiman K, David AL, Stock SJ, Norman JE, Terzidou V, Teoh TG, Sykes L, Bennett PR, Takats Z, MacIntyre DA. Pruski P, et al. Among authors: smith a. Nat Commun. 2021 Oct 13;12(1):5967. doi: 10.1038/s41467-021-26215-w. Nat Commun. 2021. PMID: 34645809 Free PMC article.

10

CHK1 protects oncogenic KRAS-expressing cells from DNA damage and is a target for pancreatic cancer treatment.

Klomp JE, Lee YS, Goodwin CM, Papke B, Klomp JA, Waters AM, Stalnecker CA, DeLiberty JM, Drizyte-Miller K, Yang R, Diehl JN, Yin HH, Pierobon M, Baldelli E, Ryan MB, Li S, Peterson J, Smith AR, Neal JT, McCormick AK, Kuo CJ, Counter CM, Petricoin EF 3rd, Cox AD, Bryant KL, Der CJ. Klomp JE, et al. Among authors: smith ar. Cell Rep. 2021 Nov 30;37(9):110060. doi: 10.1016/j.celrep.2021.110060. Cell Rep. 2021. PMID: 34852220 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results